Official Title
STUDY ECMO-COVID-19 : Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19
Brief Summary

Describe COVID-19 patients who are receiving ECMO-VV respiratory replacement and what happens to them.

Status
Completed
Conditions
Respiratory Distress Syndrome
Eligibility Criteria

Inclusion Criteria:

- Patient over the age of 18;

- Diagnostic COVID-19 by RT-PCR;

- Hospitalisation in resuscitation for the management of complications related to
COVID-19

- Implanted ECMO-VV during hospitalisation;

- Patient agreeing to participate in the study

Exclusion Criteria:

- Sujet under guardianship or trusteeship

- Sujet under safeguard of justice

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
France
Locations

Service de Chirurgie Thoracique Nouvel Hôpital Civil Hôpitaux Universitaires de Strasbourg
Strasbourg, France

Investigators

Pierre-Emmanuel FALCOZ, MD, PhD, Study Director
Service de Chirurgie Thoracique Nouvel Hôpital Civl Hôpitaux Univesitaires de Strasbourg

Sponsors / Collaborators
University Hospital, Strasbourg, France
NCT Number
NCT04343404
Keywords
Respiratory Distress Syndrome
ARDS
SARS-CoV-2
Extracorporeal membrane oxygenation
ECMO
Veno-venous ECMO
MeSH Terms
Respiratory Distress Syndrome
Respiratory Distress Syndrome, Newborn